Amyloidosis: open trials in Portugal

13 open trials have a site in Portugal. Registry data; only the trial team decides who can take part.

NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Intellia Therapeutics
Unidade Local De Saude De Santa Maria E.P.E., Lisbon
Registry updated 2026-11-04
NCT06679946
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Creixomil · Lisbon · Porto · Viseu
Registry updated 2026-10-21
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Unidade Local De Saúde De Lisboa Ocidental E.P.E., Carnaxide · Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Unidade Local De Saude Da Regiao De Leiria E.P.E., Leiria · Unidade Local De Saude De Sao Jose E.P.E., Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E., Vila Real · Unidade Local De Saude De Viseu Dao-Lafoes E.P.E., Viseu
Registry updated 2026-10-20
NCT04561518
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Research · Alnylam Pharmaceuticals
Lisbon · Porto
Registry updated 2026-10-13
NCT05040373
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Research · Alnylam Pharmaceuticals
Lisbon
Registry updated 2026-10-08
NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Unidade Local de Saúde de Santa Maria - Hopital de Santa Maria, Lisboa · Unidade Local de Saúde de Santo António - Hospital de Santo António, Porto
Registry updated 2026-10-08
NCT07235462
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Research · Bayer
Many Locations, Multiple Locations
Registry updated 2026-10-08
NCT06355934
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Research · AstraZeneca
Lisbon · Porto
Registry updated 2026-09-09
NCT07116473
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Santo Antonio E.P.E., Porto
Registry updated 2026-08-11
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Santo Antonio E.P.E., Porto
Registry updated 2026-08-04
NCT05667493
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.
Hospital da Senhora da Oliveira, Guimarães · Unidade Local de Saude do Alto Ave, E. P. E (Hospital da Senhora da Oliveira Guimaraes), Guimarães · Unidade Local de Saúde de São José, E. P. E - Hospital de Santa Marta, Lisbon · Unidade Local de Saude de Santo Antonio, E. P. E - Hospital Geral de Santo Antonio, Porto · Centro Hospitalar Universitário de São João, Porto · Centro Hospitalar Universitário do Porto - Hospital Geral de Santo Antonio, Porto · Unidade Local de Saúde de São João, EPE, Porto
Registry updated 2026-04-17
NCT07033715
Exercise in Hereditary ATTR (ATTRv) Amyloidosis
Trial Treatment · University of Maia
University of Maia, Maia
Registry updated 2025-06-24
NCT06894290
International Cardiac Amyloidosis Registry
Research · Leiden University Medical Center
Santa Marta Hospital, CHULC, Lisbon, Lisbon
Registry updated 2025-03-25

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error